Spinal Fusion Surgery with PEEK-OPTIMA™ HA Enhanced for Degenerative Disc Disease
Trial Summary
What is the purpose of this trial?
The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo spinal fusion using the Keos Lumbar Interbody Fusion Device.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on any drug treatment that affects bone metabolism, you may not be eligible to participate.
What data supports the effectiveness of the treatment Keos Lumbar Interbody Fusion Device, Keos Lumbar IBFD for degenerative disc disease?
Research shows that using PEEK (a type of plastic) rods and cages in spinal fusion surgeries can improve quality of life and reduce the need for additional surgeries. This suggests that the Keos Lumbar Interbody Fusion Device, which uses similar materials, may also be effective for treating degenerative disc disease.12345
Is the PEEK-OPTIMA™ HA Enhanced device safe for spinal fusion surgery?
Research shows that PEEK devices used in spinal fusion are generally safe, with no device degradation or harmful debris observed. Mild inflammation was noted, but PEEK systems are considered a safe alternative to traditional materials, reducing the need for further surgeries and preserving adjacent discs.12356
How is the Keos Lumbar Interbody Fusion Device treatment different from other treatments for degenerative disc disease?
The Keos Lumbar Interbody Fusion Device uses PEEK-OPTIMA™ HA Enhanced material, which is designed to improve bone fusion and reduce the risk of adjacent segment disease compared to traditional metal implants. This material is more flexible, potentially leading to better load distribution and less stress on surrounding areas, which may decrease the need for additional surgeries.13789
Research Team
Louis A Marotti, M.D. PhD
Principal Investigator
Neurosurgical Associates of Lancaster
Eligibility Criteria
This trial is for adults over 18 with lower back issues like degenerative disc disease, spondylolisthesis, or retrolisthesis needing spinal fusion surgery. Participants must have tried non-surgical treatments for at least 6 months and be able to follow study procedures. Pregnant women, smokers, drug/alcohol abusers, those with certain diseases or bone metabolism-affecting drugs are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo spinal fusion using the Keos Lumbar Interbody Fusion Device
Post-operative Follow-up
Participants are monitored for clinical outcomes, radiographic and CT outcomes
Treatment Details
Interventions
- Keos Lumbar Interbody Fusion Device
Keos Lumbar Interbody Fusion Device is already approved in United States for the following indications:
- Spinal fusion procedure at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease (DDD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Invibio Ltd
Lead Sponsor
Keos LLC
Collaborator
Medical Metrics Diagnostics, Inc
Industry Sponsor
Technomics Research
Industry Sponsor
Viedoc Technologies
Collaborator